Transporting antibodies across the blood-brain barrier to treat Alzheimer's disease

Sientists find that antibody fragments encapsulated in nanomicelles cross the blood-brain barrier and reduce the levels of toxic amyloid beta species in the brain of an Alzheimer's disease model mouse.